Showing of 0 - 10 from 125 results
Cipla - Total results - 125
Mar 06, 2017
Watch: Is PrEP the end of HIV?Array
Feb 17, 2017
Former Cipla chief, two other candidates shortlisted for Global Fund's ED postThe influential fund launched a search in November for a new chief who will take over from Mark Dybul, the current Executive Director (ED), after he finishes his tenure this year
Sep 26, 2016
Rishad Premji, Anmol Ambani and other Corporate India NextGen join crorepati clubThe annual pay of these next-generation leaders remains relatively low, as against the overall average payout of over Rs.20 crore for CEOs
Sep 02, 2016
Cipla gets USFDA nod for overactive bladder treating drugEnablex tablets and generic equivalents had US sales of approximately $85 million for the 12 month period ending June 2016
Aug 08, 2016
CEO salaries soar; average nears Rs 20 cr, AM Naik draws highest at Rs 66.14 cr in private sectorThe analysis is based on the disclosures made by 20 out of the total 24 private sector companies on the Sensex, as the remaining four are yet to disclose their figures.
Jun 06, 2016
Prices of cancer, diabetes, blood pressure drugs slashed by 25%Prices of 56 important drugs used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 percent.
Jun 06, 2016
Prices of 56 drugs to come down; NPPA fixes ceiling ratesPrices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Jan 22, 2016
FIPB clears 13 FDI proposals worth Rs 6,500 croreTelecom tower firm Viom Networks' Rs 5,900 crore FDI proposal was among the 13 projects, totalling Rs 6,500 crore, that the foreign investment promotion board (FIPB) cleared today.
Jan 06, 2016
Cipla ties up with US-based BioQ Pharma for supplying post-operative pain treatment drugBioQ Pharma and Cipla have inked a strategic distribution, supply and development agreement for the registration and commercialisation of BioQ Pharma's Ropivacaine infusion pharmaceutical in India
Dec 10, 2015
Cipla to transfer consumer healthcare business to subsidiaryThe company's board has approved the transfer of the consumer healthcare business to Cipla Health Ltd on a going concern basis by way of a slump sale for a lumpsum consideration of Rs 16 crore, Cipla said in a regulatory filing.